sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Interventional Oncology Market by Product [Ablation Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Others), Particle Embolization (Radioembolic agents, Drug-Eluting Beads, and Others), Support Devices]: Global Opportunity Analysis and Industry Forecast, 20222030

Interventional Oncology Market by Product [Ablation Radiofrequency Ablation Devices, Microwave...

Home / Categories / Other
Interventional Oncology Market by Product [Ablation Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Others), Particle Embolization (Radioembolic agents, Drug-Eluting Beads, and Others), Support Devices]: Global Opportunity Analysis and Industry Forecast, 20222030
Interventional Oncology Market by Product...
Report Code
RO14/128/2131

Publish Date
16/Aug/2022

Pages
200
PRICE
$ 4904/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5483/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8796/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global interventional oncology market size was US$ 1,981.9 million in 2021. The global interventional oncology market is expected to grow to US$ 4,121.2 million by 2030, registering a compound annual growth rate (CAGR) of 7.1% during the study period, i.e., 2022-2030.
Interventional oncology procedures encompass cancer detection and therapy using minimally invasive techniques. For guidance, professionals use efficient tools like x-ray, ultrasound, computed tomography, or magnetic resonance imaging. Ablation electrodes, guidewires, biopsy needles, and intravascular catheters are used during the operations in order to treat tumors that are located in difficult-to-reach areas of the body.

COVID-19 Impact Analysis
The overall impact of COVID-19 has been adverse on the global interventional oncology market. It is majorly owing to the obstacles faced by the manufacturers due to prolonged lockdowns and import-export restrictions, which led to the shortage of raw materials. Additionally, a significant number of medical schools and hospitals around the world underwent structural changes to expand their capacity to accommodate patients with COVID-19. The COVID-19 pandemic has detrimental effects on interventional oncology training as well. Apart from that, the substantial reduction in training chances brought on by postponing unnecessary surgery declined the demand for the interventional oncology market.

Factors Influencing the Market
Together with medical, surgical, and radiation oncology, interventional oncology is a crucial component of cancer treatment. The interventional oncology program uses image guidance to guide targeted, minimally invasive operations. The growing cases of cancer are expected to primarily prompt the demand for interventional oncology during the study period. Globocan estimates that nearly 18,094,716 million cancer cases were recorded in 2020 globally. Apart from that, the report by IARC states that the new cancer cases are expected to increase by 47% in the next 20 years.
The rising investments to improve the healthcare infrastructure is expected to open doors of opportunities for the global interventional oncology market during the analysis period. The market will also record potential growth due to the growing popularity of alternative cancer treatments such as radiation therapy, surgeries, etc.

Regional Analysis
Based on Region, North America is expected to exhibit the highest CAGR during the study period due to the rising cases of cancer.
Asia-Pacific interventional oncology market will record potential growth due to the growing efforts by governments in the form of funding for oncological treatments.

Competitors in the Market
Alpinion Medical Systems Co. Ltd.
AngioDynamics
Boston Scientific Corporation
Hologic, Inc.
Medtronic Plc.
Merit Medical
Profound Medical
Siemens Healthineers
Teleflex Incorporated
Terumo Corporation
Other Prominent Players

Market Segmentation
The global interventional oncology market segmentation focuses on Product, Procedure, Cancer, End-Users, and Region.
By Product
Embolization Devices
o Radioembolic Agents
o Non-Radio embolic Agents
? Microspheres
? Coated Beads
? Microparticles
Ablation Devices
o Radiofrequency (RF) Ablation Devices
o Microwave Ablation Devices
o Cryoablation Devices
o Other Ablation Devices
Support Devices
o Microcatheters
o Guidewires
By Procedure
Thermal Tumor Ablation
Non-Thermal Tumor Ablation
Transcatheter Arterial Chemoembolization
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
Transcatheter Arterial Embolization/Bland Embolization
By Cancer Type
Liver Cancer
Lung Cancer
Bone Metastasis
Kidney Cancer
Breast Cancer
Prostate Cancer
Other Cancers
By End Users
Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes
By Regional Outlook
? North America
o The U.S.
o Canada
o Mexico
? Europe
? Western Europe
o The UK
o Germany
o France
o Italy
o Spain
o Rest of Western Europe
? Eastern Europe
o Poland
o Russia
o Rest of Eastern Europe
? Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o ASEAN
o Rest of Asia Pacific
? Middle East & Africa (MEA)
o UAE
o Saudi Arabia
o South Africa
o Rest of MEA
? South America
o Brazil
o Argentina
o Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com